79 related articles for article (PubMed ID: 18949419)
1. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
[TBL] [Abstract][Full Text] [Related]
2. The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer.
Chen M; Liu Z; Zheng K; Hu C; Peng P
Medicine (Baltimore); 2024 Jun; 103(23):e38434. PubMed ID: 38847725
[TBL] [Abstract][Full Text] [Related]
3. FBP1 expression is associated with basal-like breast carcinoma.
Shi L; Zhao C; Pu H; Zhang Q
Oncol Lett; 2017 May; 13(5):3046-3056. PubMed ID: 28529559
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes.
Badowska-Kozakiewicz AM; Sobol M; Patera J
Arch Med Sci; 2017 Oct; 13(6):1303-1314. PubMed ID: 29181060
[TBL] [Abstract][Full Text] [Related]
5. Associations between hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms and risk of developing breast cancer.
Naidu R; Har YC; Taib NA
Neoplasma; 2009; 56(5):441-7. PubMed ID: 19580347
[TBL] [Abstract][Full Text] [Related]
6. Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer.
Ruiz-Tovar J; Fernandez-Contreras ME; Martín-Perez E; Gamallo C
Tumori; 2012; 98(3):364-9. PubMed ID: 22825513
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor 1α polymorphisms and early-stage cervical cancer.
Kim YH; Park IA; Park WY; Kim JW; Kim SC; Park NH; Song YS; Kang SB
Int J Gynecol Cancer; 2011 Jan; 21(1):2-7. PubMed ID: 21330825
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Knechtel G; Szkandera J; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Samonigg H; Renner W; Langner C; Dehchamani D; Gerger A
Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer.
Konac E; Dogan I; Onen HI; Yurdakul AS; Ozturk C; Varol A; Ekmecki A
Exp Biol Med (Maywood); 2009 Sep; 234(9):1109-16. PubMed ID: 19546348
[TBL] [Abstract][Full Text] [Related]
10. The polymorphism of hypoxia-inducible factor-1a gene in endometrial cancer.
Kafshdooz L; Tabrizi AD; Mohaddes SM; Kafshdooz T; Akbarzadeh A; Ghojazadeh M; Gharesouran J
Asian Pac J Cancer Prev; 2014; 15(23):10393-6. PubMed ID: 25556481
[TBL] [Abstract][Full Text] [Related]
11. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
[TBL] [Abstract][Full Text] [Related]
12. Effect of genetic polymorphisms rs2301113 and rs2057482 in the expression of HIF-1α protein in periodontal ligament fibroblasts subjected to compressive force.
Küchler EC; Teodoro VB; Schröder A; Nazet U; Meger MN; Kunz PVM; Baratto-Filho F; Spanier G; Scariot R; Proff P; Kirschneck C
J Appl Oral Sci; 2023; 31():e20220151. PubMed ID: 37255180
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.
de Rauglaudre B; Sibertin-Blanc C; Fabre A; Le Malicot K; Bennouna J; Ghiringhelli F; Taïeb J; Boige V; Bouché O; Chatellier T; Faroux R; François E; Jacquot S; Genet D; Mulot C; Olschwang S; Seitz JF; Aparicio T; Dahan L
Ther Adv Med Oncol; 2022; 14():17588359221141307. PubMed ID: 36601631
[TBL] [Abstract][Full Text] [Related]
14. The impact of COVID-19 on populations living at high altitude: Role of hypoxia-inducible factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication.
Devaux CA; Raoult D
Front Physiol; 2022; 13():960308. PubMed ID: 36091390
[TBL] [Abstract][Full Text] [Related]
15. Sclareol Inhibits Hypoxia-Inducible Factor-1α Accumulation and Induces Apoptosis in Hypoxic Cancer Cells.
Vandghanooni S; Farajzadeh Vahid Z; Nakhlband A; Bahadori MB; Eskandani M
Adv Pharm Bull; 2022 May; 12(3):593-602. PubMed ID: 35935045
[No Abstract] [Full Text] [Related]
16. Association of
Islam MS; Jesmin
JCO Glob Oncol; 2022 Mar; 8():e2100399. PubMed ID: 35507894
[TBL] [Abstract][Full Text] [Related]
17. Association of HIF1-α gene polymorphisms with advanced non-small cell lung cancer prognosis in patients receiving radiation therapy.
Zhang Y; Wang J; Li Z
Aging (Albany NY); 2021 Feb; 13(5):6849-6865. PubMed ID: 33621198
[TBL] [Abstract][Full Text] [Related]
18. Association between HIF-1α gene polymorphisms and lung cancer: A meta-analysis.
Xu S; Ying K
Medicine (Baltimore); 2020 Jun; 99(24):e20610. PubMed ID: 32541494
[TBL] [Abstract][Full Text] [Related]
19.
Li HN; He T; Zha YJ; Du F; Liu J; Lin HR; Yang WZ
J Cancer; 2019; 10(24):5955-5963. PubMed ID: 31762805
[TBL] [Abstract][Full Text] [Related]
20. Association of the hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms with prognosis in ovarian clear cell carcinoma.
Suzuki H; Yano M; Miyazawa M; Miyazawa M; Ogane N; Hasegawa K; Tsuda H; Yoshida M; Okagaki R; Ishihara O; Yasuda M
J Ovarian Res; 2019 Jan; 12(1):7. PubMed ID: 30678691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
